[go: up one dir, main page]

MX9802000A - Sales de adicion de acido de compuestos de 2,3,4,5-tetrahidro-1h-3-benzacepina. - Google Patents

Sales de adicion de acido de compuestos de 2,3,4,5-tetrahidro-1h-3-benzacepina.

Info

Publication number
MX9802000A
MX9802000A MX9802000A MX9802000A MX9802000A MX 9802000 A MX9802000 A MX 9802000A MX 9802000 A MX9802000 A MX 9802000A MX 9802000 A MX9802000 A MX 9802000A MX 9802000 A MX9802000 A MX 9802000A
Authority
MX
Mexico
Prior art keywords
tetrahydro
acid addition
addition salts
benzazepine compounds
benzazepine
Prior art date
Application number
MX9802000A
Other languages
English (en)
Other versions
MXPA98002000A (es
Inventor
Louis Brammer Hansen
Rolf Emil Amsler
Scott Eugene Mcgraw
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of MX9802000A publication Critical patent/MX9802000A/es
Publication of MXPA98002000A publication Critical patent/MXPA98002000A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

La invencion una serie de sales cristalinas de (S)(+)-8-cloro-5-(5,6-dicloro-2,3-dihidrobenzofura n-7-il)-3-metil-2,3,4,5-tetrahidro-1H-3-benzacepin -7-ol, su preparacion y uso como agentes terapéuticos.
MXPA/A/1998/002000A 1995-09-15 1998-03-13 Sales de adicion de acido de compuestos de 2,3,4,5-tetrahidro-1h-3-benzacepina MXPA98002000A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK1030/95 1995-09-15
DK103095 1995-09-15

Publications (2)

Publication Number Publication Date
MX9802000A true MX9802000A (es) 1998-08-30
MXPA98002000A MXPA98002000A (es) 1998-11-12

Family

ID=

Also Published As

Publication number Publication date
HUP9900746A2 (hu) 1999-09-28
CA2231848A1 (en) 1997-03-20
AU700596B2 (en) 1999-01-07
WO1997010239A1 (en) 1997-03-20
IL123602A0 (en) 1998-10-30
CN1200121A (zh) 1998-11-25
BR9610162A (pt) 1999-01-05
HUP9900746A3 (en) 1999-11-29
KR19990044648A (ko) 1999-06-25
NO981135L (no) 1998-03-13
CZ77898A3 (cs) 1998-07-15
NO981135D0 (no) 1998-03-13
EP0850237A1 (en) 1998-07-01
PL325514A1 (en) 1998-08-03
AU6923596A (en) 1997-04-01
JPH11512403A (ja) 1999-10-26

Similar Documents

Publication Publication Date Title
PL310171A1 (en) Novel imidazopyridines
IL117848A0 (en) Novel compounds a process for their production and pharmacetical compositions containing same
WO1996032003A3 (en) Tetrahydroimidazopyridoindolediones and their use as medicaments
BG103485A (en) Ketobanzamides as calpain inhibitors
CA2198238A1 (en) Piperidine derivatives as neurokinin antagonists
GR3036813T3 (en) Novel n-(1-alkyl-5-phenyl-2,3,4,5-tetrahydro-1h-benzo[b][1,4]diazepin-3-yl)-acetamides
MX9605741A (es) Clorhidrato cristalino del (r)-(-)-2-{n-[4-(1,1-dioxido-3-oxo-2,3-dihidro-benzisotiazol-2-il)-butil ]-aminometil} cromano.
AP2000001947A0 (en) Novel crystalline forms of an antiviral benzidazole compound.
AU1945495A (en) Acid addition salts of 2,3,4,5-tetrahydro-1h-3-benzazepine compounds
MD1560F2 (en) Cyclic compounds, pharmaceutical compositions on base thereof and methods of treatment of infections or diseases provoked by retroviruses.
NZ515025A (en) Solvates of pymetrozine
MY132057A (en) Quinoxalinones, a process for their preparation and their use
TW252979B (es)
IL107068A0 (en) 5-oxo-dibenzo(a,d)cyclohepta-1,4-dienes,their preparation and pharmaceutical compositions containing them
IL108288A0 (en) Pyrrolidine derivatives, their preparation and medicaments containing them
IL109866A (en) Crystalline 3-(4-hexyloxy-1,2,5-thiadiazol-3-yl)-1,2,5,6-tetrahydro-1-methylpyridine(+)L-hydrogentartrate its preparation and pharmaceutical compositions containing it
MX9802000A (es) Sales de adicion de acido de compuestos de 2,3,4,5-tetrahidro-1h-3-benzacepina.
HUT71523A (en) Gestagenically active 19,11-bridged 4-estrenes and pharmaceutical compositions containing the same
IL112110A0 (en) Octahydro-1h-isoindoles and pharmaceutical compositions containing them
TR200000154T2 (tr) 2,4,4-Trisübstitüe-1,3-Dioksolan mantar önleyiciler.
HUP9800032A3 (en) 3-aryluracil-derivatives, preparation and use thereof, herbicidal compositions containing these compounds and preparation of the latest
GR3031709T3 (en) Octahydro-2-naphthalenecarboxylic acid derivative, its production and use.
TR199800958A2 (xx) Herbisidal 3,5-Difloropridinleri.
BR9809286A (pt) Processos para redução de fibrinogênio
UA23368A (uk) Використання (1,1-діоксотіолан-3-іл) диктіокарбамату калію як антимікробного засобу